Sean Levine

| Associate Director of Research

Sean Levine is Associate Director of Research at Weiss Ratings, joining the company in March 2026. He is an investment banker, attorney, securities analyst, entrepreneur and consultant with a focus on fundamental and technical stock and commodity analysis, trading system development, private placements and crowdfunding, energy markets and policy intelligence. Levine has substantial experience supporting issuer clients through the Regulation A+ exempt securities offering process, having worked from 2020 until 2025 with a number of broker-dealers, crowdfunding platforms and digital marketing firms. During this time, he supported clients in raising over $70 million through exemptions under the JOBS Act. From 2015 to 2020, he led a research team focused on design, development and optimization of unconventional/innovative trading systems. Prior to this, he wrote and published newsletters and reports on the oil and gas industry, private and public companies in multiple sectors, economic and geopolitical dynamics. Levine holds the Series 7, 63, 24, 86, and 87 securities licenses, and is a licensed attorney in West Virginia.

Sean Levine's Products
Sean Levine's Articles
Health insurers jumped, AI data-center stocks slid, and one looming Treasury deadline could matter more than either.
The rally’s hottest names include three Sell-rated stocks. Here are the winners our ratings actually back.
Smaller companies fell harder than the S&P 500. Here’s where the damage hit, and how our ratings could have helped you dodge it.
The S&P 500 slipped, but the average stock rose. Here’s where the money went, and how to follow it.
Anthropic stock could start trading on Nasdaq before Thanksgiving. Here’s what the S-1 tells us about the maker of Claude, including its talk of the end of mankind.
Day One Syndicate Subscription
The filing is out. A pre-Thanksgiving debut looks likely. And yes, the risk factors discuss the end of mankind.
Day One Syndicate Subscription Alert
This IPO is trading at a discount to where it started.
Day One Syndicate Subscription Your Issue
Nine new-to-market stocks, one sector and a second wave that may already be starting.
SpaceX will benefit from tens of billions of dollars soon.
And you probably won’t even notice it!